The main limitation of the present study is the lack of euglycemic-hyperinsulinemic clamp and assessment of fatty liver, as well as recognized diagnostic tests for NAFLD because NAFLD is a cause of liver insulin resistance development and decreased SHBG synthesis. The gene discussed is SHBG; the disease is metabolic dysfunction-associated steatotic liver disease.